Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Kalkine 0
countryflagAU

Rhythm Biosciences Ltd

Healthcare AU RHY

0.059AUD
-0.003(4.84%)

Last update at 2025-06-13T03:45:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.040.14
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap16.76M
  • Volume196507
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.02276M
  • Revenue TTM3.17M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM 4.02M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -8.21756M -8.79352M -6.61215M -4.02298M -2.54616M
Minority interest - - - - -
Net income -8.21756M -6.31618M -7.72105M -4.13078M -1.37748M
Selling general administrative 7.33M 5.33M 2.97M 2.00M 2.28M
Selling and marketing expenses 0.18M 0.56M 0.06M 0.04M 0.30M
Gross profit -0.32673M -0.17238M -2.17580M -1.35153M -1.47686M
Reconciled depreciation 0.19M 0.10M 0.15M 0.14M 0.07M
Ebit -11.54167M -11.24589M -6.61175M -4.01519M -3.71484M
Ebitda -11.35229M -11.14441M -6.46510M -3.87390M -3.64948M
Depreciation and amortization 0.19M 0.10M 0.15M 0.14M 0.07M
Non operating income net other - - - - -
Operating income -11.54167M -11.24589M -6.61175M -4.01519M -3.71484M
Other operating expenses 11.54M 11.25M 7.73M 4.16M 3.71M
Interest expense - 0.02M 0.00040M 0.00780M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.23M 0.02M 0.01M 0.00780M 0.14M
Net interest income 0.23M 0.02M 0.01M 0.04M 0.14M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.22827M -2.47734M 1.11M 0.11M -1.16868M
Total revenue 0.23M 0.02M 0.01M 0.05M 0.14M
Total operating expenses 11.54M 11.25M 7.73M 4.16M 3.71M
Cost of revenue 0.56M 0.20M 2.19M 1.40M 1.62M
Total other income expense net 3.10M 2.45M -0.00040M -0.00780M 1.17M
Discontinued operations - - - - -
Net income from continuing ops -8.21756M -8.79352M -6.61215M -4.02298M -2.54616M
Net income applicable to common shares -8.21756M -8.79352M -6.61215M -4.02298M -2.54616M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 1.52M 7.70M 8.44M 3.07M 2.65M
Intangible assets - 0.39M 0.43M 0.46M 0.50M
Earning assets - - - - -
Other current assets 0.09M 0.12M 0.09M 0.06M 0.02M
Total liab 0.65M 1.82M 1.07M 1.36M 0.80M
Total stockholder equity 0.87M 5.87M 7.37M 1.71M 1.84M
Deferred long term liab - - - - -
Other current liab 0.27M 0.35M 0.57M 0.74M 0.19M
Common stock 34.45M 31.55M 27.83M 15.98M 10.04M
Capital stock - 31.55M 27.83M 15.98M 10.04M
Retained earnings -38.67417M -31.81741M -23.59986M -14.80633M -8.38819M
Other liab - 0.06M 0.05M 0.02M 0.00843M
Good will - - - - -
Other assets 0.00000M - - - -
Cash 0.71M 4.12M 7.55M 2.23M 1.80M
Cash and equivalents - - - 2.23M 1.80M
Total current liabilities 0.56M 1.77M 0.93M 1.34M 0.79M
Current deferred revenue - - - - -
Net debt -0.54567M -4.03958M -7.38028M -2.22840M -1.75552M
Short term debt 0.08M 0.08M 0.09M 0.00000M 0.04M
Short long term debt - - - - -
Short long term debt total 0.16M 0.08M 0.17M - 0.04M
Other stockholder equity - 6.14M 3.14M 0.53M 0.19M
Property plant equipment - 0.10M 0.24M 0.11M 0.14M
Total current assets 0.89M 7.12M 7.77M 2.49M 2.01M
Long term investments - - - - -
Net tangible assets - 5.48M 6.95M 1.24M 1.35M
Short term investments 0.04M 0.04M 0.04M 0.04M 0.04M
Net receivables 0.04M 0.07M 0.08M 0.16M 0.14M
Long term debt - - - - -
Inventory - 2.77M - - -
Accounts payable 0.21M 1.33M 0.28M 0.60M 0.56M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 5.09M 6.14M 3.14M 0.53M 0.19M
Additional paid in capital - - - - -
Common stock total equity - - - - 10.04M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.35M - - -0.00003M -
Deferred long term asset charges - - - - -
Non current assets total 0.63M 0.58M 0.67M 0.58M 0.64M
Capital lease obligations - 0.08M 0.17M - 0.04M
Long term debt total - 0.00000M 0.08M 0.00000M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.09912M -0.02701M -0.06827M -0.04553M -0.11026M
Change to liabilities 0.00000M -0.55232M 0.51M 0.36M 0.16M
Total cashflows from investing activities -0.09912M -0.02701M -0.06827M -0.04553M -0.11026M
Net borrowings -0.08553M -0.00766M -0.04244M -0.14222M -0.14222M
Total cash from financing activities 3.63M 11.85M 5.90M -0.14222M -0.14222M
Change to operating activities -0.07549M 0.07M 0.04M 0.02M 0.04M
Net income -8.21756M -6.31618M -6.61215M -4.02298M -2.54616M
Change in cash -3.42624M 5.32M 0.43M -2.93036M -3.05186M
Begin period cash flow 7.55M 2.23M 1.80M 4.73M 7.78M
End period cash flow 4.12M 7.55M 2.23M 1.80M 4.73M
Total cash from operating activities -6.95761M -6.21471M -5.40249M -2.74260M -2.94160M
Issuance of capital stock 3.74M 12.32M 6.17M - -
Depreciation 0.19M 0.10M 0.15M 0.14M 0.07M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - -
Change to inventory -2.76668M -2.76668M -2.76668M -2.76668M -
Change to account receivables 0.91M 0.07M -0.04020M 0.66M -0.76246M
Sale purchase of stock -0.02422M -0.46785M -0.22512M - 0.00000M
Other cashflows from financing activities -0.08553M -0.00766M -0.04244M -0.05986M -0.11026M
Change to netincome 3.00M 2.61M 0.56M 0.10M 0.09M
Capital expenditures 0.10M 0.03M 0.07M 0.05M 0.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 3.32M 2.45M 1.18M 0.84M 0.43M
Stock based compensation - - - - -
Other non cash items - 6.21M 6.47M 3.88M 2.48M
Free cash flow -0.09912M -6.24171M -0.06827M -0.04553M -0.11026M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
RHY
Rhythm Biosciences Ltd		 -0.003 4.84% 0.06 - - 5.56 3.61 -11.0908
SHL
Sonic Healthcare Ltd		 0.05 0.19% 26.89 23.39 21.28 1.37 1.56 1.83 9.75
IDX
Integral Diagnostics Ltd		 -0.02 0.87% 2.29 115.50 16.31 1.75 1.23 2.76 18.33
HLS
Healius Ltd		 -0.015 1.80% 0.82 - 74.07 0.34 0.58 1.08 10.14
ACL
Australian Clinical Labs Ltd		 -0.09 3.19% 2.73 18.80 13.28 0.76 3.20 1.15 4.55

Reports Covered

Stock Research & News

View All

Profile

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia.

Rhythm Biosciences Ltd

Bio21 Institute, Parkville, VIC, Australia, 3010

Key Executives

Name Title Year Born
Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD Exec. Chairman 1964
Mr. Glenn Gilbert MD, CEO & Director NA
Dr. Trevor John Lockett Ph.D. Technical Director, Chair of the Clinical Advisory Board & Exec. Director NA
Mr. Paul Smith Chief Financial Officer & Joint Company Sec. NA
Ms. Andrea Steele LLB B Com LLM Gen. Counsel & Company Sec. NA
Ms. Elena Deak Chief Commercial Officer NA
Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD Executive Chairman 1964
Mr. Guy Carisbrooke Financial Controller NA
Ms. Andrea Steele LLB B Com LLM General Counsel & Joint Company Secretary NA
Mr. James Stephen Barrie CPA Joint Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.